Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
RP-101 by Redwood Pharma for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval
RP-101 is under clinical development by Redwood Pharma and currently in Phase II for Keratoconjunctivitis Sicca (Dry Eye). According to...